BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 28683244)

  • 1. A patient preference study that evaluated fluticasone furoate and mometasone furoate nasal sprays for allergic rhinitis.
    Yanez A; Dimitroff A; Bremner P; Rhee CS; Luscombe G; Prillaman BA; Johnson N
    Allergy Rhinol (Providence); 2016 Jan; 7(4):183-192. PubMed ID: 28683244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preference evaluation and perceived sensory comparison of fluticasone furoate and mometasone furoate intranasal sprays in allergic rhinitis.
    Yonezaki M; Akiyama K; Karaki M; Goto R; Inamoto R; Samukawa Y; Kobayashi R; Kobayashi E; Hoshikawa H
    Auris Nasus Larynx; 2016 Jun; 43(3):292-7. PubMed ID: 26498699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of Intranasal Corticosteroid Sensory Attributes and Patient Preference for Fluticasone Furoate for the Treatment of Allergic Rhinitis.
    May JR; Dolen WK
    Clin Ther; 2019 Aug; 41(8):1589-1596. PubMed ID: 31402060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preferences of adult patients with allergic rhinitis for the sensory attributes of fluticasone furoate versus fluticasone propionate nasal sprays: a randomized, multicenter, double-blind, single-dose, crossover study.
    Meltzer EO; Stahlman JE; Leflein J; Meltzer S; Lim J; Dalal AA; Prillaman BA; Philpot EE
    Clin Ther; 2008 Feb; 30(2):271-9. PubMed ID: 18343265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A preference evaluation study comparing the sensory attributes of mometasone furoate and fluticasone propionate nasal sprays by patients with allergic rhinitis.
    Meltzer EO; Bardelas J; Goldsobel A; Kaiser H
    Treat Respir Med; 2005; 4(4):289-96. PubMed ID: 16086602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A patient preference and satisfaction study of ciclesonide nasal aerosol and mometasone furoate aqueous nasal spray in patients with perennial allergic rhinitis.
    Berger WE; Prenner B; Turner R; Meltzer EO
    Allergy Asthma Proc; 2013; 34(6):542-50. PubMed ID: 24169063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of patient preference for sensory attributes of fluticasone furoate or fluticasone propionate in adults with seasonal allergic rhinitis: a randomized, placebo-controlled, double-blind study.
    Meltzer EO; Andrews C; Journeay GE; Lim J; Prillaman BA; Garris C; Philpot E
    Ann Allergy Asthma Immunol; 2010 Apr; 104(4):331-8. PubMed ID: 20408344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of sensory attributes and immediate efficacy of intranasal ciclesonide and fluticasone propionate in allergic rhinitis: a randomized controlled trial.
    Varshney J; Varshney H; Dutta SK; Hazra A
    Indian J Pharmacol; 2012; 44(5):550-4. PubMed ID: 23112411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of patients' preferences for triamcinolone acetonide aqueous, fluticasone propionate, and mometasone furoate nasal sprays in patients with allergic rhinitis.
    Stokes M; Amorosi SL; Thompson D; Dupclay L; Garcia J; Georges G
    Otolaryngol Head Neck Surg; 2004 Sep; 131(3):225-31. PubMed ID: 15365540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. No mucosal atrophy and reduced inflammatory cells: active-controlled trial with yearlong fluticasone furoate nasal spray.
    Fokkens WJ; Rinia B; van Drunen CM; Hellings PW; Hens G; Jansen A; Blom H; Wu W; Clements DS; Lee LA; Philpot EE
    Am J Rhinol Allergy; 2012; 26(1):36-44. PubMed ID: 22391079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patient preferences and sensory comparisons of three intranasal corticosteroids for the treatment of allergic rhinitis.
    Bachert C; El-Akkad T
    Ann Allergy Asthma Immunol; 2002 Sep; 89(3):292-7. PubMed ID: 12269650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient Satisfaction and Sensory Attributes of Nasal Spray Treatments of Olopatadine Hydrochloride/Mometasone Furoate Monohydrate and Azelastine Hydrochloride/Fluticasone Propionate for Allergic Rhinitis in Australia - An Observational Real-World Clinical Study.
    Fifer S; Toh L; Barkate H; Aggarwal V; Borade D; Gordonsmith RH; Wu W; Morgan C; Young K
    Patient Prefer Adherence; 2023; 17():141-151. PubMed ID: 36687019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two multicenter, randomized, single-blind, single-dose, crossover studies of specific sensory attributes of budesonide aqueous nasal spray and fluticasone propionate nasal spray.
    Shah SR; Miller C; Pethick N; Uryniak T; Jones MK; O'Dowd L
    Clin Ther; 2003 Aug; 25(8):2198-214. PubMed ID: 14512128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of sensory perceptions and patient preference for intranasal corticosteroid sprays in allergic rhinitis.
    Khanna P; Shah A
    Am J Rhinol; 2005; 19(3):316-21. PubMed ID: 16011141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluticasone furoate nasal spray is effective and well tolerated for perennial allergic rhinitis in adolescents and adults.
    Given JT; Cheema AS; Dreykluft T; Stillerman A; Silvey M; Wu W; Snowise NG; Philpot E
    Am J Rhinol Allergy; 2010; 24(6):444-50. PubMed ID: 21144223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nasal deposition of ciclesonide nasal aerosol and mometasone aqueous nasal spray in allergic rhinitis patients.
    Emanuel IA; Blaiss MS; Meltzer EO; Evans P; Connor A
    Am J Rhinol Allergy; 2014; 28(2):117-21. PubMed ID: 24598007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of mometasone furoate nasal spray for nasal symptoms, quality of life, rhinitis-disturbed sleep, and nasal nitric oxide in patients with perennial allergic rhinitis.
    Yamada T; Yamamoto H; Kubo S; Sakashita M; Tokunaga T; Susuki D; Narita N; Ogi K; Kanno M; Yamashita S; Terasawa Y; Kayano Y; Masada M; Fujieda S
    Allergy Asthma Proc; 2012; 33(2):e9-16. PubMed ID: 22525384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of once daily mometasone furoate (Nasonex) and fluticasone propionate aqueous nasal sprays for the treatment of perennial rhinitis. 194-079 Study Group.
    Mandl M; Nolop K; Lutsky BN
    Ann Allergy Asthma Immunol; 1997 Oct; 79(4):370-8. PubMed ID: 9357385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mometasone furoate nasal spray plus oxymetazoline nasal spray: short-term efficacy and safety in seasonal allergic rhinitis.
    Meltzer EO; Bernstein DI; Prenner BM; Berger WE; Shekar T; Teper AA
    Am J Rhinol Allergy; 2013; 27(2):102-8. PubMed ID: 23562197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mometasone furoate nasal spray is rapidly effective in the treatment of seasonal allergic rhinitis in an outdoor (park), acute exposure setting.
    Berkowitz RB; Roberson S; Zora J; Capano D; Chen R; Lutz C; Harris AG
    Allergy Asthma Proc; 1999; 20(3):167-72. PubMed ID: 10389549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.